A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course MyNeuroNews, 16 Jul 2020 Background: The diagnostic use of biomarkers in body fluids of multiple sclerosis (MS) patients allows the monitoring of…
